Drug intelligence / Profile preview

alkalinized mepivacaine chlorhydrate + epinephrine

Development stage
Phase 4
Lead developer
Università Campus Bio-Medico di Roma
Modality
Small Molecules
Administration
Local Infiltration
01

Overview

This is an alkalinized formulation of mepivacaine chlorhydrate (2%) and epinephrine, specifically diluted with 1.4% sodium bicarbonate. Developed and studied by Campus Bio-Medico University, it is intended for local infiltration anesthesia during ambulatory phlebectomy procedures for varicose veins. Mepivacaine is an amide-type local anesthetic that works by blocking voltage-gated sodium channels in nerve cell membranes, thereby preventing the initiation and conduction of pain signals. Epinephrine is included as a vasoconstrictor to prolong the duration of the anesthetic effect and minimize systemic absorption. The addition of sodium bicarbonate serves as an alkalinizing agent to raise the pH of the solution, which is intended to reduce the stinging pain associated with the infiltration of the typically acidic local anesthetic solution and potentially speed up the onset of action.

Other names
mepivacaine chlorhydrate 2% in sodium bicarbonate 1.4% with epinephrinealkalinized 2% mepivacaine with epinephrine
02

Targets

ADRA1A (α1A)ADRB1 (β1)SCN10A (Sodium channel protein type X alpha subunit)ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on alkalinized mepivacaine chlorhydrate + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alkalinized mepivacaine chlorhydrate + epinephrine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call